Literature DB >> 4330312

Antibiotic susceptibilities of Serratia marcescens and Enterobacter liquefaciens.

P Greenup, D J Blazevic.   

Abstract

Production of 5'-nucleotides by Serratia marcescens and Enterobacter liquefaciens correlates with deoxyribonuclease production, indicating the close relationship between these two organisms. To determine further relationships, susceptibilities of 279 strains of the tribe Klebsielleae were determined by the high-potency disc method, agar-dilution method, or both, by using 14 antibiotics. Ninety-seven per cent of S. marcescens (201 of 207 strains) and 100% of E. liquefaciens (17 strains) had minimum inhibitory concentration (MIC) of 100 mug/ml or greater with colistin and polymyxin B. With these two antibiotics, 93% of other Enterobacter species (28 strains) had MIC values of less than 1.6 mug/ml, and 100% of Klebsiella (27 strains) had MIC values less than 1.6 mug/ml. Consistent patterns were not noted with the other antibiotics tested, but the results with colistin and polymyxin B provide additional evidence of the close relationship of S. marcescens and E. liquefaciens.

Entities:  

Mesh:

Substances:

Year:  1971        PMID: 4330312      PMCID: PMC376305          DOI: 10.1128/am.22.3.309-314.1971

Source DB:  PubMed          Journal:  Appl Microbiol        ISSN: 0003-6919


  15 in total

1.  The Klebsiella-Enterobacter (Aerobacter)-Serratia group. A clinical and bacteriological evaluation.

Authors:  E B Edmondson; J P Sanford
Journal:  Medicine (Baltimore)       Date:  1967-07       Impact factor: 1.889

2.  Sensitivity tests of klebsiella, enterobacter, and serratia.

Authors:  J P Sanford
Journal:  J Infect Dis       Date:  1969 Apr-May       Impact factor: 5.226

3.  Differentiation of Klebsiella-Enterobacter (Aerobacter)-Serratia by biochemical tests and antibiotic susceptibility.

Authors:  M J Ramirez
Journal:  Appl Microbiol       Date:  1968-10

4.  Sensitivity studies on Serratia strains from clinical specimens.

Authors:  A von Graevenitz
Journal:  Chemotherapy       Date:  1967       Impact factor: 2.544

5.  Modification of deoxyribonuclease test medium for rapid identification of Serratia marcescens.

Authors:  J B Schreier
Journal:  Am J Clin Pathol       Date:  1969-06       Impact factor: 2.493

6.  The deoxyribonuclease test as applied to certain gram-negative bacteria.

Authors:  W J Martin; W H Ewing
Journal:  Can J Microbiol       Date:  1967-05       Impact factor: 2.419

7.  Differentiation of Serratia from Enterobacter on the basis of nucleoside phosphotransferase production.

Authors:  A M Durand; D J Blazevic
Journal:  Appl Microbiol       Date:  1970-01

8.  Antibiotic susceptibility testing by a standardized single disk method.

Authors:  A W Bauer; W M Kirby; J C Sherris; M Turck
Journal:  Am J Clin Pathol       Date:  1966-04       Impact factor: 2.493

9.  Klebsiella, Enterobacter, and Serratia: biochemical differentiation and susceptibility to ampicillin and three cephalosporin derivatives.

Authors:  R J Zabransky; J W Hall; F E Day; G M Needham
Journal:  Appl Microbiol       Date:  1969-08

10.  Serratia marcescens: biochemical, serological, and epidemiological characteristics and antibiotic susceptibility of strains isolated at Boston City Hospital.

Authors:  J N Wilfert; F F Barrett; W H Ewing; M Finland; E H Kass
Journal:  Appl Microbiol       Date:  1970-02
View more
  9 in total

1.  Antibacterial activity of selected beta-lactam and aminoglycoside antibiotics against cephalothin-resistant Enterobacteriaceae.

Authors:  R P Lewis; R D Meyer; L L Kraus
Journal:  Antimicrob Agents Chemother       Date:  1976-05       Impact factor: 5.191

2.  Isolation of Serratia marcescens on deoxyribonuclease-toluidine blue-cephalothin agar.

Authors:  J J Farmer; F Silva; D R Williams
Journal:  Appl Microbiol       Date:  1973-01

3.  Antibiotic resistance patterns of clinical isolates of Serratia marcescens.

Authors:  R C Cooksey; E R Bannister; W E Farrar
Journal:  Antimicrob Agents Chemother       Date:  1975-04       Impact factor: 5.191

4.  Hospital isolates of Serratia marcescens transferring ampicillin, carbenicillin, and gentamicin resistance to other gram-negative bacteria including Pseudomonas aeruginosa.

Authors:  V M Olexy; T J Bird; H G Grieble; S K Farrand
Journal:  Antimicrob Agents Chemother       Date:  1979-01       Impact factor: 5.191

5.  In vitro activity of gentamicin, amikacin and netilmicin alone and in combination with carbenicillin against Serratia marcescens.

Authors:  S M Pogwizd; S A Lerner
Journal:  Antimicrob Agents Chemother       Date:  1976-12       Impact factor: 5.191

6.  R factor-mediated antibiotic resistance in Serratia marcescens.

Authors:  R C Cooksey; G M Thorne; W E Farrar
Journal:  Antimicrob Agents Chemother       Date:  1976-07       Impact factor: 5.191

7.  Antimicrobial susceptibility of clinical isolates of Serratia marcescens.

Authors:  J S Alvarez; B Regueiro; M J Garrido
Journal:  Antimicrob Agents Chemother       Date:  1979-10       Impact factor: 5.191

8.  Nalidixic acid susceptibility testing of clinical isolates of Serratia marcescens.

Authors:  J D Jollick; E M Schervish-Swierkosz; W J Brown
Journal:  Antimicrob Agents Chemother       Date:  1973-11       Impact factor: 5.191

9.  Selective medium for primary isolation of members of the tribe Proteeae.

Authors:  E Urbanová
Journal:  Folia Microbiol (Praha)       Date:  1999       Impact factor: 2.629

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.